Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating epilepsia and preparation method

A drug and epilepsy technology, applied in the field of epilepsy drugs and preparations, can solve the problems of adverse drug reactions, anti-epileptic western drugs cannot effectively control seizures, etc.

Inactive Publication Date: 2018-03-20
成都图瑞思舟科技有限公司
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The present invention provides a medicine for treating epilepsy and its preparation method, which solves the technical problem that the antiepileptic western medicine cannot effectively control its seizures in the prior art, and this kind of medicine generally has relatively serious adverse reactions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating epilepsia and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0014] In order to make the above objects, features and advantages of the present invention more clearly understood, the present invention will be described in further detail below with reference to the accompanying drawings and specific embodiments.

[0015] The embodiment of the present invention provides a medicine for treating epilepsy, comprising: 10-30 parts by weight of gentian grass extract, 10-20 parts by weight of Scutellaria baicalensis water extract, 5-15 parts by weight of salvia miltiorrhiza alcohol extract, 20 parts by weight of angelica alba -40 parts by weight, 5-15 parts by weight of Ophiopogon japonicus water extract.

[0016] A preferred embodiment includes: 10 parts by weight of gentian grass extract, 10 parts by weight of water extract of Scutellaria baicalensis, 5 parts by weight of alcohol extract of Salvia miltiorrhiza, 30 parts by weight of alcohol extract of Angelica sinensis, and 5 parts by weight of water extract of Ophiopogon japonicus.

[0017] T...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of treatment of epilepsia and discloses a medicine for treating epilepsia and a preparation method. The medicine is prepared from the following components in parts by weight: 10 to 30 parts of radix gentianae extracts, 10 to 20 parts of radix scutellariae water extracts, 5 to 15 parts of radix salviae miltiorrhizae alcohol extracts, 20 to 40 parts of radix angelicae sinensis alcohol extracts, and 5 to 15 parts of radix ophiopogonis water extracts. The radix angelicae sinensis alcohol extracts of the medicine disclosed by the invention has a convulsion symptomcaused by reducing pentylenetetrazole, has treatment effects on reduction of convulsion death ratios, delay of death time, prolong of convulsion latent time and the like, and also has the treatment effects on resisting convulsion and epilepsia.

Description

technical field [0001] The invention relates to the field of epilepsy treatment, in particular to a medicine for treating epilepsy and a preparation method. Background technique [0002] Epilepsy (EP) is a group of chronic onset symptoms based on abnormal electrical activity of nerve cells. According to reports, the prevalence of epilepsy in developed countries is 0.1%, and the prevalence in some parts of the country is as high as 0.36%-0.48%. At present, the treatment of epilepsy at home and abroad is still dominated by drugs, and some patients need lifelong medication to effectively control their seizures; about 30% of patients have refractory epilepsy, and traditional anti-epileptic western medicines cannot effectively control their seizures, and such drugs generally have More serious adverse reactions include bone marrow suppression, exfoliative dermatitis (carbamazepine, sodium valproate), cardiotoxicity (phenytoin sodium), etc. SUMMARY OF THE INVENTION [0003] The...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8968A61P25/08A61K33/26
CPCA61K33/26A61K36/232A61K36/233A61K36/515A61K36/537A61K36/539A61K36/68A61K36/804A61K36/8968A61K2236/33A61K2236/331A61K2236/39A61K2300/00
Inventor 赖朋卓图强宋宏玉
Owner 成都图瑞思舟科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products